Chemoinformaics analysis of 2,6-dimethyl-1,3,5,7-octatetraene
| Molecular Weight | 134.222 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 4 |
| Exact Molecular Weight | 134.11 | nRing | 0 |
| Solubility: LogS | -2.54 | nHRing | 0 |
| Solubility: LogP | 2.267 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.52 |
| Synth | 3.471 |
| Natural Product Likeliness | 2.799 |
| NR-PPAR-gamma | 0.129 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.388 |
| MDCK | 0.0000301 |
| BBB | 0.964 |
| PPB | 0.825111 |
| VDSS | 1.606 |
| FU | 0.162983 |
| CYP1A2-inh | 0.633 |
| CYP1A2-sub | 0.824 |
| CYP2c19-inh | 0.141 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.96 |
| CYP2d6-inh | 0.228 |
| CYP2d6-sub | 0.923 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.184 |
| CL | 6.926 |
| T12 | 0.654 |
| hERG | 0.01 |
| Ames | 0.118 |
| ROA | 0.296 |
| SkinSen | 0.916 |
| Carcinogencity | 0.797 |
| EI | 0.995 |
| Respiratory | 0.952 |
| NR-Aromatase | 0.131 |
| Antiviral | No |
| Prediction | 0.950042 |